Evaluating Treatment Selections for Chronic Cough: Managed Care Considerations

Evaluating Treatment Selections for Chronic Cough: Managed Care Considerations

On-Demand 1.5-hour Accredited Webcast

Faculty Presenters

Phung C. On, PharmD, BCPS
Assistant Professor of Pharmacy Practice
MCPHS University School of Pharmacy - Boston
Boston, Massachusetts

Winston Wong, PharmD
President
W-Squared Group
Longboat Key, Florida
 
Program Description
The excessive coughing associated with chronic cough can have a substantial impact on a person’s quality of life. A range of complications, including vomiting, muscle pain, syncope, and fractures exacerbated by coughing, can accompany this condition and contribute to increased healthcare costs and hospitalizations for patients. The pathophysiology of chronic cough, particularly refractory and unexplained cough, can be complicated, and managed care professionals should be aware of the evolving definitions and classifications of the disease. For patients with chronic cough, achieving relief is the main goal of supportive therapies, such as antitussives, narcotics, or corticosteroids, as there are currently no available FDA-approved treatments specifically indicated for chronic cough. However, new and emerging agents with novel mechanisms of action could decrease the burden on healthcare resources, families, work and school, and improve patients’ quality of life and overall health. This interactive discussion will review how the emerging agents for chronic cough work, important guideline updates, and standard assessment tools for managed care professionals that can be used to assess patients and ensure initiation of appropriate therapy to help improve their quality of life.

Target Audience: Managed care pharmacists
Type of Activity: Application
Release date: June 29, 2021
Expiration date: June 29, 2022
Time to complete activity: 1.5 hours
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Explore the pathophysiology of chronic cough and review the burden associated with the condition
• Examine the guidelines for chronic cough and discuss current and emerging therapies used for management
• Determine the role of the managed care professional in creating a targeted treatment plan that maximizes patient outcomes and quality of life and minimizes the economic and social burdens associated with chronic cough

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-21-268-H01-P. The activity is available for CE credit through June 29, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Faculty

Winston Wong, PharmD, and Phung C. On, PharmD, BCPS, have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer has been used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this live CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms